PMID- 17600126 OWN - NLM STAT- MEDLINE DCOM- 20070913 LR - 20181113 IS - 0002-9440 (Print) IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 171 IP - 2 DP - 2007 Aug TI - Hypoxia-inducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice. PG - 667-81 AB - Advanced cervical cancer remains a vexing clinical challenge despite screening programs. Many of these cancers are hypoxic, and expression of the alpha subunit of the major regulator of the hypoxic cellular response, the transcription factor hypoxia-inducible factor-1 (HIF-1), is correlated with poor prognosis. Here, we tested a functional role for HIF-1alpha in pathogenesis of cervical cancer in estrogen-treated transgenic mice. Double-transgenic (DTG) mice developed locally invasive cervical cancers 70 times larger than K14-HPV16 mice. In vivo bromodeoxyuridine incorporation was elevated in DTG cancers without a significant increase in apoptosis. HIF-1alpha gain of function did not up-regulate canonical HIF-1 targets in premalignant DTG cervices, in contrast to elevation of these targets in K14-HIF-1alpha transgenic cervices. The DTG transcriptional signature included up-regulation of mRNAs encoding cytokines and chemokines, immune signaling molecules, extracellular proteases, and cell motility factors, as well as reduced expression of cell adhesion and epithelial differentiation genes. Importantly, a set of gene markers derived from the DTG transcriptome predicted cervical cancer progression in patients. This study suggests a novel paradigm for HIF-1 function evident in multistage carcinogenesis as opposed to established malignancies, including interaction with viral oncogenes to induce multiple genomic networks in premalignancy that fosters the development of advanced cervical cancer. FAU - Lu, Zhi Hong AU - Lu ZH AD - Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA. luz@wudosis.wustl.edu FAU - Wright, Jason D AU - Wright JD FAU - Belt, Brian AU - Belt B FAU - Cardiff, Robert D AU - Cardiff RD FAU - Arbeit, Jeffrey M AU - Arbeit JM LA - eng GR - T32 CA009621/CA/NCI NIH HHS/United States GR - R01-90722/PHS HHS/United States GR - T32CA 009621-17/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070628 PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (BNip3 protein, mouse) RN - 0 (Estrogens) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Keratin-14) RN - 0 (Membrane Proteins) RN - 0 (Mitochondrial Proteins) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Animals MH - Apoptosis/genetics/physiology MH - Caspase 3/genetics/metabolism MH - Cervix Uteri/metabolism/pathology MH - Cluster Analysis MH - Disease Progression MH - Estrogens/administration & dosage MH - Female MH - Gene Expression Profiling MH - Gene Expression Regulation, Neoplastic MH - Human papillomavirus 16/*genetics/physiology MH - Hypoxia-Inducible Factor 1, alpha Subunit/*genetics/physiology MH - Immunohistochemistry MH - Keratin-14/genetics/physiology MH - Membrane Proteins/genetics/metabolism MH - Mice MH - Mice, Transgenic MH - Mitochondrial Proteins/genetics/metabolism MH - Mutation MH - Oligonucleotide Array Sequence Analysis/methods MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transcription, Genetic MH - Uterine Cervical Neoplasms/genetics/metabolism/*pathology PMC - PMC1934541 EDAT- 2007/06/30 09:00 MHDA- 2007/09/14 09:00 PMCR- 2008/02/01 CRDT- 2007/06/30 09:00 PHST- 2007/06/30 09:00 [pubmed] PHST- 2007/09/14 09:00 [medline] PHST- 2007/06/30 09:00 [entrez] PHST- 2008/02/01 00:00 [pmc-release] AID - S0002-9440(10)61999-2 [pii] AID - 10.2353/ajpath.2007.061138 [doi] PST - ppublish SO - Am J Pathol. 2007 Aug;171(2):667-81. doi: 10.2353/ajpath.2007.061138. Epub 2007 Jun 28.